Previous studies have revealed a robust association between exposure to asbestos and human lung cancer. Accumulating evidence has highlighted the role of epigenome deregulation in the mechanism of carcinogen-induced malignancies. We examined the impact of asbestos on DNA methylation. Our genome-wide studies (using Illumina HumanMethylation450K BeadChip) of lung cancer tissue and paired normal lung from 28 asbestos-exposed or non-exposed patients, mostly smokers, revealed distinctive DNA methylation changes. We identified a number of differentially methylated regions (DMR) and differentially variable, differentially methylated CpGs (DVMC), with individual CpGs further validated by pyrosequencing in an independent series of 91 non-small cell lung cancer and paired normal lung. We discovered and validated BEND4, ZSCAN31 and GPR135 as significantly hypermethylated in lung cancer. DMRs in genes such as RARB (FDR 1. , mean D 20.11), and DVMCs in NPTN, NRG2, GLT25D2 and TRPC3 (all with p <0.05, t-test) were significantly associated with asbestos exposure status in exposed versus non-exposed lung tumors. Hypomethylation was characteristic to DVMCs in lung cancer tissue from asbestos-exposed subjects. When DVMCs related to asbestos or smoking were analyzed, 96% of the elements were unique to either of the exposures, consistent with the concept that the methylation changes in tumors may be specific for risk factors. In conclusion, we identified novel DNA methylation changes associated with lung tumors and asbestos exposure, suggesting that changes may be present in causal pathway from asbestos exposure to lung cancer.
humans. 3 Given that the latency of cancer development may be as long as 30-40 years after asbestos exposure and the fact that demolition of asbestos-containing buildings is common, asbestos exposure will continue to inflict substantial suffering in future years. 3, 5 Despite the fact that link between asbestos and lung cancer risk is well-established, asbestos-associated neoplasms have proven difficult to diagnose early and treat successfully, underscoring the need for better understanding of the molecular mechanisms and identification of critical gene targets for new therapies and biomarkers.
The putative carcinogenic effects of asbestos fibers involve both direct and indirect mechanisms but a more comprehensive understanding at the molecular level is lacking. 6 Our pioneering genomic investigations have revealed changes in miRNA profile and an accumulation of genomic alterations in asbestos-related lung cancer. [7] [8] [9] Not only miRNAs but also other epigenetic mechanisms, such as DNA methylation are fundamental in the regulation of gene expression and carcinogenesis. Cancer has been characterized by global DNA hypomethylation-targeting often the non-coding regions-as well as site-specific hypermethylation of CpG islands (CGI) in tumor suppressor gene promoters. However, recent findings point to more complex gene regulation for instance, involving CGI shores and gene body methylation. 10, 11 There is accumulating evidence that the establishment and maintenance of DNA methylation states may be sensitive to environmental influences and can trigger mechanisms crucial to tumorigenesis. [12] [13] [14] [15] However, DNA methylation changes in fiber-related pulmonary carcinogenesis await clarification. In malignant pleural mesothelioma, restricted DNA methylation profiles were predictive for the asbestos burden of the patients. 16 With respect to lung cancer, very limited data on DNA methylation in asbestos-exposed patients have been published, with CDKN2A being the best studied candidate gene but so far with discrepant results. 14, 15, [17] [18] [19] This highlights the need to understand more comprehensively the role of DNA methylation in asbestos-related lung cancer. First, we carried out a genome-wide DNA methylation array analysis in lung cancer and the paired normal peripheral lung tissue from cases for whom detailed exposure data were available, using a unified strategy for differentially methylated DNA regions (DMRs) and differentially variable, differentially methylated CpGs (DVMCs). 20 This was followed by a validation study using a larger independent series of lung cancer cases. We present here evidence that asbestos exposure may induce DNA methylation changes in specific genes and pathways, pointing to mechanisms that may contribute to lung carcinogenesis.
Material and Methods

Lung cancer and normal lung tissue samples
In the discovery study, fresh-frozen (FF) lung cancer samples and their corresponding microscopically normal peripheral lung tissues from 28 lung surgery Caucasian male patients were collected in the Department of Thoracic and Cardiovascular Surgery of the Helsinki University Central Hospital in 1989-1995. These tissues are subsequently referred to as "tumor/T" and "normal/N." As controls, we used microscopically normal lung tissue (subsequently called "control/C") from six non-cancer male patients. The control patients had non-malignant disorders such as tuberculoma, hamartoma, lymphoid hyperplasia or inflammatory pseudotumor. The specimens were taken outside of the pathological region. Moreover, an additional 91 sample pairs (tumor and peripheral normal lung) from Caucasian males were obtained from different Central Hospitals in Finland.
Asbestos exposure and cigarette smoking of the patients. Work histories based on interview data and pulmonary fiber counts, determined using scanning electron microscopy with energy dispersive spectrometry, 21 were used to evaluate exposure to asbestos among the study subjects. We used the pulmonary fiber counts for defining the groups of exposed and non-exposed in the study population. In our discovery study population (Supporting Information Table  S1 ), the pulmonary fiber count ranged from 5.9 3 10 6 to 145 3 10 6 fibers/gram dry lung tissue (median 11.7 3 10 6 f/g) for 14 asbestos-exposed lung cancer patients. Furthermore, the patients were classified as having had definite or probable exposure to asbestos according to their interview-based work histories evaluated by an experienced industrial hygienist. The 14 lung cancer patients grouped in the discovery study as non-exposed, had pulmonary fiber counts ranging from 0 to 0.5 3 10 6 f/g (median 0.0 3 10 6 f/g) and were classified as unlikely or possibly exposed (two exceptions classified as probable exposed to asbestos but with pulmonary fiber count at the non-exposed level [0 f/g]). In the control non-cancer patients, the fiber count ranged from 0 to 3.0 3 10 6 f/g (median 1.9 3 10 6 f/g), and they were classified as having possible or probable exposure to asbestos based on their work histories. No known history of occupational asbestos exposure nor pulmonary fiber count data was available for two non-cancer control subjects.
In the validation series of 91 patients, the pulmonary fiber count ranged from 1.0 3 10 6 to 570 3 10 6 f/g (median 2.0 3 10 6 f/g) among the exposed and from 0 to 0.5 3 10 6 f/g (median 0.2 3 10 6 f/g) among the non-exposed (Supporting Information Table S2 ). There were data on interview-based work histories for two-thirds (n 5 61) of the validation series cases. All lung cancer cases were either current or former smokers, with one life-long non-smoker in both the discovery and validation series. For three non-cancer patients, the smoking data were missing. The data for average pack-years of cigarette-smoking (PY; one PY 5 one year of smoking 20 cigarettes/day), other detailed demographics, occupational exposure and histopathology are shown in Supporting Information Table S1 for the discovery study group and in Supporting Information Table S2 Tables S1 and S2 ) gave their written informed consent and underwent a personal interview about their smoking and work history, whereas the FFPE sample collection from deceased patients (Supporting Information  Table S2 ) was approved by Ethical Review Boards.
DNA extraction and bisulfite conversion
Hematoxylin-Eosin stained sections from all lung tissues were microscopically evaluated by experienced pathologists (H.W., S.A. and K.Sa). Only representative normal lung tissues and tumors having at least 60% of tumor cells (with a mean of close to 80%) were included in the study. DNA was extracted using standard procedures. Bisulfite conversion of DNA was performed with the EZ DNA Methylation kit (Zymo Research Corp., Irvine, CA; Infinium BeadChip) or with the EpiTectV R Fast 96 Bisulfite Kit (Qiagen GmbH, Hilden, Germany; pyrosequencing) according to manufacturers' instructions. The quality of modification was tested by standard PCR using primers for bisulfite converted and unconverted GAPDH gene.
Methylation arrays
For methylation profiling, the converted DNA was hybridized onto Infinium HumanMethylation 450 K (HM450K) BeadChip (Illumina, San Diego, CA). The procedure for the methylation array was conducted following the recommended protocols for amplification, labeling, hybridization and scanning.
Differential methylation analysis/bioinformatics analysis
The overall strategy for bioinformatics analysis of differential methylation using a unified analysis strategy is illustrated in Supporting Information Fig. S1a . The detailed analyses are described in Supporting Information. Technical array replicates revealed an excellent correlation between the experiments (Spearman correlation coefficient r 5 0.9850, p < 0.0001, Supporting Information Fig. S1b) .
Pyrosequencing
In the validations of HM450K results, we examined selected CpG sites by bisulfite pyrosequencing as previously described. 22 To confirm the conversion efficiency, non-CpG cytosines were included in the studied sequences. Briefly, approximately 9-18 ng of bisulfite converted DNA was used in pyrosequencing which was carried out in PSQ96MA (Qiagen GmbH, Hilden, Germany). Primers designed are shown in Supporting Information Table S4 ).
RESULTS
To study potential influence of asbestos exposure on the DNA methylome in lung cancer, we performed genome-wide DNA methylation profiling for both tumor (T) and paired peripheral normal lung tissue (N) of 28 lung cancer cases, half of whom had been exposed to asbestos. Microscopically normal lung tissues from six non-cancer patients were used as controls (C). An initial multidimensional scaling plot of the Illumina HM450K array result showed that T were more dispersed in terms of methylation compared to N, with the exceptions of a few N samples (Supporting Information Fig.  S3a ). Relations between samples according to hierarchical clustering based on differential methylation are shown in Supporting Information Fig. S3b . The highest mean for genome-wide methylation was detected in lung from noncancer patients whereas the lowest mean was present in tumor tissues (Supporting Information Fig. S3c ). The genome-wide mean methylation levels were lower in lung tumor and peripheral normal lung tissue of the asbestosexposed subjects than those in their non-exposed counterparts (Supporting Information Fig. S3d ).
In more detailed analyses, we identified differentially methylated DNA regions (DMRs) and significantly differentially variable, differentially methylated CpGs, DVMCs as in Ref. 20 . Finally, individual sites were further studied for validation using pyrosequencing in an independent series of lung cancer cases with or without occupational exposure to asbestos.
Differentially methylated DNA regions in lung cancer in a genome-wide analysis
To reduce data dimensionality and to demonstrate differential methylation integrated over several gene areas, we analyzed our methylation data for differentially methylated regions (DMR). DMRs were defined as regions with at least two CpGs displaying significant (FDR < 0.05) methylation differences to the same direction and at least 0.05 or 0.10 (i.e., 5 or 10% change) of mean change in methylation beta value (D).
DNA methylation in lung cancer tissue and normal peripheral lung. First, we compared T and N using paired samples of lung tissue for DMRs. We identified 6,529 statistically significant DMRs (D 0.05; FDR < 0.05) of variable number of CpGs (from 2 to 170 CpGs). Among these, the greatest mean D was 0.1766, and 822 of the DMRs had a mean D of 0.10. The top DMRs resided in genes such as HOXD9 and HOXD10, HOXD3, ZNF311, DRD4, LOC648987, MIR10B, HOXD8, ZNF577, SEPT9 and ZSCAN31/ZNF323, with many of them ontologically related and hypermethylated in the tumors (Supporting Information Table S5 : DMR_T vs. N). Most of the above mentioned DMRs (9/12; 75%) resided within gene promoters.
DNA methylation in relation to asbestos exposure status. To examine whether distinct DNA methylation changes associated with asbestos exposure status, we next compared methylation as DMRs in T and N between the asbestos-exposed and non-exposed cases. In dichotomous exposure groups (asbestos-vs. non-exposed), we identified 132 DMRs (FDR <0.05) in T and N associated with asbestos exposure status of the patients. These DMRs located on genes such as RARB and APC (Supporting Information Table S5 : DMR_asbestos). The number of CpGs among the DMRs ranged from 2 to 16, the top mean D being 20.223 for a 25 bp sequence in RPTOR. In addition to RPTOR, ZAN, TMEM132D, AACSP1 and PAX7 met the criteria of mean D 0.10 and FDR < 0.05.
The analysis performed with tumors only identified 529 asbestos exposure status-associated DMRs (FDR <0.05) with the number of CpGs ranging from 2 to 38 (Supporting Information Table S5 : DMR_asbestos_tumors). Of note, 95 of the DMRs had mean D 0.10. The top mean D was 20.2091, indicating hypomethylation in asbestos-exposed tumors for RPTOR. By FDR values, the most significant DMR of 866 bp was in promoter region of RARB. In RARB DMR, methylation was lower in tumors from asbestos-exposed cases, and the DMR exhibited virtually no variation as compared to that in tumors from non-exposed patients (Fig. 1a) . Another DMR (FDR < 0.05, D 0.10) covered 2,106 bp of GPR135 and was overlapping with a CGI, showing lowered methylation with narrow range of variation in tumors from the asbestos-exposed cases (Fig. 1b) . In contrast, the above mentioned DMR in RPTOR intron 1 showed larger range of variation and lowered methylation in the tumors of asbestosexposed cases (Fig. 1c) . Genes such as TPO and MYT1L displayed more than one DMR showing significant asbestosrelated hypomethylation in lung tumors (D 0.10, FDR <0.05, Supporting Information Table S5 : DMR_tumors_asbes-tos, Figs. 1d and 1e). Accordingly, in pyrosequencing analysis, we detected significantly more pronounced hypomethylation in TPO in lung tumors of the asbestos-exposed subjects than in their non-exposed counterparts (p 5 0.014 Mann Whitney test, two-tailed, Supporting Information Fig. S4 ).
DNA methylation in relation to smoking pack-years. Since the majority of study subjects (27 out of 28) were either current or former smokers and association between smoking and aberrant methylation have been widely reported, 23 we looked at effects of smoking by using pack-years of smoking as a continuous variable. Our analysis showed 578 smokingrelated DMRs (FDR < 0.05). The number of CpGs in DMRs ranged from 2 to 56 and the top mean D was 20.0049 indicating slight but statistically significant change towards hypomethylation (Supporting Information Table S5 : DMR_smoking).
For smoking, we also analyzed differentially methylated positions (DMPs) for associations with PYs. Eight DMPs were associated with smoking (FDR < 0.05, Supporting Information Table S5 : DMP_smoking; Supporting Information Table S6 ) and exhibited lower methylation with higher PYs. These DMPs resided in regulatory region or within the genes NEDD4L, IRX2, RASGRF1, KCNK9, LHFPL2, TSSC1, GIMAP7 and EXOC3 (Supporting Information Fig. S5 ). Despite an overall decrease in methylation levels, the majority of PY-related DMPs still exhibited relatively high mean methylation levels in many of the lung tumor and normal tissues.
Differentially variable and differentially methylated CpGs
DVMCs in lung cancer. Due to the implications of increased methylation variability related to cancer, we next identified using iEVORA 20 (2) in lung tumors from the asbestos-exposed subjects compared to those from the non-exposed patients and (3) in tumors from the non-asbestos exposed subjects in association with smoking Cancer Genetics and Epigenetics Table 1 . Unsupervised clustering of the top DVMCs, ranked by p(TT), showed clear major clusters of T and N, with more variability in tumors than in normal peripheral lung (Fig. 2a) .
Hypomethylation is a characteristic of DVMCs in lung cancer from asbestos-exposed subjects. DVMCs were next explored by comparing tumors from cases with asbestos exposure to tumors from the non-exposed subjects. We identified 999 asbestos exposure status-related DVMCs (adjusted q(BT) < 0.001 and p(TT) < 0.05, Supporting Information Table S5 : DVMC_tumors_asbestos) that displayed mostly low methylation levels in the asbestos-exposed cases, whereas the highest methylation levels were clearly concentrated in the non-exposed tumors (Fig. 2b) . Unsupervised clustering of the top 50 DVMCs in tumors revealed a few major groups (Fig. 2c) . A respective analysis of non-tumor tissues revealed up to 860 asbestos-related statistically significant DVMCs (Supporting Information Table S5 : DVMC_nontumors_asbestos). In unsupervised clustering of the top 50 DVMCs, two clear-cut groups were formed (Fig. 2d) . The proportion of hypomethylated DVMCs was strikingly increased in lung tumors of asbestos-exposed cases in comparison to those in non-tumor tissue of asbestos-exposed cases and particularly so in comparison to DVMCs in T versus N (Fig. 2e) . We examined the genes indicated as having asbestos-related significant DVMCs; 673 were discovered in tumors only and 687 similarly in non-tumor lung tissue only (Fig. 2f) . Moreover, when the genomic distribution of DVMCs was examined, there were remarkably more asbestos-related DVMCs located within 1-kb promoter region in tumors than in asbestosrelated DVMCs in non-tumor tissue or DVMCs in T versus N (Supporting Information Fig. S6 ). With respect to the distinct top 30 asbestos-related variable DVMCs in lung tumors (Table 1) , only cg06332339 in NPTN showed the highest methylation in tumors of the asbestos-exposed cases. For instance, DVMCs that displayed higher methylation rates and wide variations in tumor tissue from the non-exposed cases resided within NRG2, ANKRD34A, NGFR, NEURL1, TRPC3 and GLT25D2/COLGALT2 (Table 1) .
Finally, when T and N were analyzed together in relation to the asbestos exposure status of the patients, a total of 1,833 CpGs met the criteria for statistically significant DVMCs (Supporting Information Table S5 : DVMC_asbes-tos). Unsupervised clustering of the top 50 DVMCs is shown in Figure 2g .
Tobacco smoking and asbestos have distinct DNA methylation targets in lung tumors. We also studied smoking-related DVMCs using PYs as the dichotomous measure of accumulated tobacco smoking exposure (>36 vs. 36 PY). Non-asbestos-exposed and asbestos-exposed cases were profiled separately. Analyses of T and N from the nonasbestos-exposed cases identified 15,139 DVMCs, and the T versus N comparison among the asbestos-exposed revealed 1,740 DVMCs that were significantly associated with PY (adjusted q(BT) < 0.001 and p(TT) < 0.05, Supporting Information Table S5 : DVMC_smoking_in_non-asb; DVMC_smo-king_in_asb_exp). When we evaluated the effect of smoking alone on methylation variability, certain CpGs such as cg13751927 (F2RL3), cg15658543 (CARD11), cg22019569 (SMYD3), cg26812418 (CPE) and, interestingly, 11 CpGs of AHRR (aryl-hydrocarbon receptor repressor) were shown among the smoking-related DVMCs when focusing on the cases without occupational asbestos exposure (Supporting Information Table S5 : DVMC_smoking_in_non-asb). Unsupervised clustering of the top 50 DVMCs showed that in the non-asbestos-exposed smokers, a higher smoking burden associated with a higher variability (Fig. 2h) whereas, in contrast, in the asbestos-exposed smokers, the highest methylation variability concentrated in two clusters of patients having 36 PY (Fig. 2i) . In the asbestos-exposed lungs, comparison between the genes exhibiting DVMCs related to smoking PYs and those with DVMCs related to asbestos exposure status showed that 96% of the elements were unique to either smoking or asbestos exposure (Fig. 2j) .
Enrichment analysis for GO classification terms. In comparison with the T versus N assessment, the gene ontology (GO) classification terms for biological processes most enriched (2) in lung tumors from the asbestos-exposed subjects compared to those from the non-exposed patients and (3) in tumors from the non-asbestos exposed subjects in association with smoking (Continued) 
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among DVMCs included "embryonic morphogenesis," "tissue morphogenesis" and "synaptic transmission" (Fig. 3a Supporting Information Table S5 : GO_Biol_Proc_in DVMC_T vs. N). With respect to molecular function, several significantly enriched terms, such as channel activity and glycosaminoglycan binding, were identified in the T versus N Figure 2 .
2022
DNA methylation profiles in lung cancer analysis (Supporting Information Table S5 : GO_Mol Funct_in DVMC_T vs. N). Also for DMRs in T versus N assessment, the "embryonic morphogenesis" was the most significant term (data not shown).
The biological processes most enriched among asbestos exposure status-related DVMCs in lung tumor tissue included "Positive regulation of nervous system development," "-neurogenesis," "-neuron differentiation" as well as "-cell development" (Fig. 3b , Supporting Information Table  S5 :GO_Biol_Proc_in DVMC_Asb_tumors) whereas RNA polymerase II regulatory region DNA binding and calmodulin binding were shown as significantly enriched molecular functions (Fig. 3c , Supporting Information Table S5 :GO_Mol Funct_in DVMC_Asb_tumors). For asbestos exposure statusrelated DMRs, statistically the most significantly enriched biological process concerned potassium ion transport and regulation of neuron differentiation (data not shown).
For smoking-related DMRs, the biological process most statistically significantly enriched in GO terms was "a cellular response to nitrogen compound" (data not shown).
Biological validation of distinct CpGs displaying novelty in methylation pattern
Biological validation in an independent case series was performed on specific CpGs in NPTN, NEURL, BEND4, GPR135 and ZSCAN31. We discovered NPTN (cg06332339) and NEURL (cg25066490) among the genes with significant methylation variation in the lung tumors of the non-exposed subjects. These were among the genes classified as being implicated in the positive regulation of neurogenesis (Fig. 4a) . In the discovery series, methylation in NPTN/cg06332339 showed a coefficient of variation (CV) of 29.8% in tumors of the non-exposed patients whereas in tumors of the asbestos-exposed, CV was only 0.5% (Fig. 4a) . In the validation series of lung cancer, CV was 26.5% in lung tumors of the non-exposed (n 5 29) and 24.0% in those of the asbestosexposed subjects (n 5 24); however, the exposed patient group in the validation series differed from that in the discovery series, in terms of a broader pulmonary fiber count range, thus preventing direct comparison of these series (Fig. 4b) .
In the discovery series, NEURL/cg25066490 had CV of 99.0% in tumors of the non-exposed patients (methylation ranging from 3.5 to 40.4%), whereas in tumors of the asbestosexposed patients, the CV was 14.3% (methylation ranging from 3.3 to 5.3%, Fig. 4a ). In the validation group, methylation of cg25066490 in tumors ranged from 0 to 16.1% in the nonexposed (n 5 46) and from 0 to 9.2% in the asbestos-exposed subjects (n 5 32, Fig. 4c ). CVs were not calculated in the validation series, due to the very low mean methylation values.
We discovered hypermethylation as statistically significant DVMCs within the transcription start site (TSS200) and the first exon/5 0 UTR of the BEND4/CCDC4 in T as compared with N ( Fig. 5a ). They were located on a CGI in BEND4 (Fig. 5b) . Our pyrosequencing analysis replicated the hypermethylation in this region in lung tumors, with a difference of 11.1% in mean methylation in the validation series for cg10172669 between paired T and N (n 5 77, Fig. 5c ). Furthermore, we revealed in the discovery series and confirmed in the validation series hypermethylation of specific CpGs in GPR135 (cg09859398, n 5 67 pairs, Figs. 5df) and ZSCAN31/ZNF323 (cg21138752, n 5 72 pairs, Figs. 5gi) in lung tumors in comparison with normal lung. The difference in mean methylation in T versus N was 6.6% for GPR135 and 23.4% for ZSCAN31 (Figs. 5f and 5i) .
DISCUSSION
Environmental and lifestyle factors are recognized as influencing an individual's DNA methylation patterns. 12 As Figure 2 . (a) Heat map for the top 50 differentially variable and differentially methylated CpGs (DVMCs) showing the lowest p(TT) (TT, t-test) in lung tumors versus peripheral normal lung, methylation variability mostly in tumors; (b) heat map for supervised clustering of the asbestos-related 999 DVMCs in lung tumors, the exposed cases tend to display hypomethylation; (c) heat map for the top 50 asbestos linked DVMCs in lung tumors: most often non-exposed tumors exhibited higher Z scores than the exposed ones; (d) heat map for the top 50 asbestos linked DVMCs in non-tumor tissue (i.e., normal peripheral lung from cancer patients and lung tissue from non-cancer patients): clear clusters of the non-exposed and the exposed cases, the latter again showing more hypomethylation. Interestingly, among the exposed group cluster, there is a sample from a patient that had been suggested as "occupationally probably asbestos-exposed" on the basis of the interview with an experienced industrial hygienist although his pulmonary asbestos fiber count was 0. (e) A histogram showing proportions of hypermethylation and hypomethylation among DVMCs related to asbestos exposure in lung tumors (Asbestos T) and in non-tumors (Asbestos N) and among DVMCs in all T vs. N; (f) Venn diagram for genes that were detected as an asbestos exposure status-related differential variable and differentially methylated CpGs (DVMCs) in non-tumor lung tissue or lung tumor tissue; (g) heat map for the top 50 DVMCs (by p(TT)) related to asbestos exposure status in lung tumor and normal peripheral lung tissue: clear clusters were formed based on they methylation pattern (with one exception in both clusters), the asbestos-exposed cases exhibiting primarily low level of methylation with less variation in methylation, while in some of the tumor and lung tissues from the non-exposed cases, the same CpG sites showed hypermethylation; (h) heat map for DVMCs related to tobacco smoking pack-years (PY) in lung tumor and normal peripheral lung tissue of non-asbestos exposed cases: hypomethylation mostly occurred in lung tissues of heavy smokers (PY >36, purple bar) whereas smokers with PY 36 (grey bar) had a more homogeneous methylation pattern; (i) heat map for DVMCs related to tobacco smoking pack-years (PY) in lung tumor and normal peripheral lung tissue of asbestos-exposed cases: heavy smokers (PY > 36, purple bar) displayed homogeneous methylation while smokers with PY 36 clustered in three groups; (j) Venn diagram for genes that were located in DVMC in lung tumor and normal peripheral lung tissue related to smoking pack years (PY) in asbestos-exposed patients or related to asbestos exposure status. Samples in all heat maps are in columns and CpGs (details shown in Supporting Information Table S5 ) are in rows. Different histologic types were distributed in all groups. In all heat maps, the color key indicates the methylation level (Z score) of each site (red, higher; blue, lower). [Color figure can be viewed at wileyonlinelibrary.com] Figure 3 . Gene ontology (GO) classification terms for (a) biological processes enriched most in the T versus N comparison among the 6,224 unique gene symbols representing 15,470 significant DVMCs. "Embryonic morphogenesis" included 187 genes such as HOXA11, HOXA10, HOXB1, HOXB2, PSEN2 and GATA2, "Tissue morphogenesis" 169 genes such as NPNT, HOXB2 and CA2 and "Synaptic transmission" 196 genes. All terms with adj.p < 0.05 are shown in Supporting Information Table S5 : GO_Biol_Proc_in DVMC_T vs. N; (b) biological processes enriched most in lung tumor tissue of asbestos-exposed versus non-exposed patients among the 737 gene symbols representing 999 significant DVMPs. Positive regulation of "nervous system development," "neurogenesis," "neuron differentiation" as well as "cell development" included each 30 to 37 genes such as NPTN, NGFR and NEURL1. All terms with adj.p < 0.05 are shown in Supporting Information far as we are aware, our study provides the first genome-wide DNA methylation profiling of asbestos-related lung cancer. We validated the data by pyrosequencing, revealing a high overall concordance with correlation coefficient values at the level shown earlier in primary tumor specimens. 24 Moreover, biological validation for distinct CpGs was performed in an independent case series, with results supporting the findings emerging from the array data. Our analyses revealed DNA methylation changes in lung cancer in novel sites such as those in BEND4 and ZSCAN31. In our DMR analyses, we also found differential methylation in novel sites in GPR135, TPO, NPTN, NRG2, TRPC3 and GLT25D2, all associating with asbestos exposure status of the patient (FDR < 0.05, mean D 0.05 or 0.10). DMR analyses showed regions with mean change of >10% (up to 17% in T vs. N and 22% in relation to asbestos exposure, mostly towards hypomethylation). The corresponding maximum changes were 28% and 30%, respectively. Analysis of T compared to N also identified many DMRs hypermethylated in tumors in ontologically-related genes, such as several HOX family genes.
Growing awareness of increased stochastic variability in methylation of distinct genomic regions in cancer tissue has raised interest in methylation heterogeneity and methylation variability in carcinogenesis. 25, 26 Therefore, we included in our analyses the iEVORA procedure to identify DVMCs. 20 A total of 15,470 DVMCs were found in the T versus N comparison, the top 50 DVMCs revealing distinguishable major clusters of lung cancers and normal tissues, with more overall variation in cancer tissue. We found 1,833 DVMCs significantly associated with asbestos exposure. Larger methylation variability was common among lung tumors from cases without occupational exposure to asbestos, whereas in lung tumors of the asbestos-exposed subjects, the proportion of hypomethylated DVMCs was strikingly high, in comparison to those in asbestos-related DVMCs of non-tumor tissue and to T versus N. Of note, a large proportion of these DVMCs found in lung tumors of the asbestos-exposed subjects were located within 1 kb of promoter regions. The GO analysis implicated biological processes such as positive regulation of neurogenesis and cell development within DVMCs identified in lung cancers in relation to asbestos.
Statistically significant asbestos-related DVMCs resided with genes such as NPTN, NRG2 and TRPC3. In lung tumors, NRG2 (neuregulin) has been suggested as involved in the control of cell proliferation and survival. 27 Although the role of NPTN (neuroplastin) [particularly the short isoform] remains unclear, it has been postulated to be involved in modulating intracellular Ca 21 as a result of its interaction with FGFR. 28 Stimulation of a Ca 21 sensing receptor has been shown to promote the expression of TRPC3, a member of the canonical transient receptor potential channels, leading to perturbation in Ca 21 homeostasis. 29 We found TRPC3 methylation variation prominent in lung cancer from cases without asbestos exposure, whereas in tumors of the asbestos-exposed, TRPC3 methylation remained at the same level as in peripheral lung tissue. It has been reported that asbestos can trigger release of Ca 21 in alveolar epithelial cells. 30 As well-documented occupational exposure data was available for our cases, we were able to identify association between asbestos and several DMRs, including genes such as RARB, GPR135, MYT1L, TPO and RPTOR with mean change of 0.22. TPO and MYT1L showed several DMRs associated with asbestos exposure. The current study is the first to reveal putative asbestos-associated hypomethylation of TPO in lung tumors. TPO encodes thyroid peroxidase involved in oxidative metabolic reactions, mostly studied in thyroid cells. 31 Of note in this context is that asbestos-related mechanisms of carcinogenesis are known to involve reactive oxygen species (ROS). 32 To follow this line of speculative points, it is interesting that increased expression of TPO has been observed in tumor/lung tissue of adenocarcinoma patients with high intakes of red meat; the increased expression was attributed to a gene product linked to heme-iron toxicity and oxidative stress. 33 Iron-related toxicity mechanisms have also been proposed for asbestos. 3 Importantly, TPO expression was not found to be associated with smoking in lung adenocarcinoma. 33 This is also the first time that hypermethylation of the BEND4 (BEN domain containing 4/CCDC4) has been detected at several CpG sites in lung tumor tissue; this was also replicated in the validation series. Hypermethylated BEND4 has been previously postulated as a novel biomarker candidate for colorectal cancer, 34 even though its function is unknown. We also discovered and replicated in the validation series of lung cancers novel hypermethylation of specific CpGs in GPR135 (G-protein coupled receptor) and ZSCAN31. Previously, GPR135 has been reported to be hypermethylated in epithelial-mesenchymal transition induced by TGF-beta in ovarian cancer cells. 35 ZSCAN31 is thought to act as a transcription factor; it is claimed to be involved in airway structure or remodeling, with genetic variants leading to lowered lung function. 36 Differential methylation was shown in T versus N also for the first time within zinc finger proteins ZNF311, ZNF831 and ZIC5. Furthermore, we discovered statistically significant DMRs and DVMCs in GATA2, SEPT9, FBLN2, PTPRN2, PRDM16 and RASSF1 in the T versus N comparison independent of the asbestos exposure status. Epigenetic regulation of these genes has been strongly implicated earlier in lung cancer. [37] [38] [39] [40] [41] However, methylation in genes such as CDKN2A did not cross the thresholds in our study possibly because differing methylation patterns in CDKN2A has been reported in different lung cancer histological types. 42 We detected smoking-related methylation changes in several CpGs or genes that have earlier been reported to associate with smoking. These included DVMCs in CARD11 (cg15658543), SMYD3 (cg22019569), CPE (cg26812418) and AHRR (cg08491376, cg00401753) and as many as 87% (7/8) of the smoking-associated genes with DMP in our study. 23, 43, 44 However, the smoking-related mean methylation changes discovered in our DMR analysis were minor, possibly because we compared two groups of smokers, having either lower (36) or higher pack-years (>36). Interestingly though, we detected cg13751927 in F2RL3 as a smoking-linked significant DVMC in T and N. The cg13751927 located in a CGI in F2RL3 at a range of only 299 nucleotides from cg03636183; lowered methylation of cg03636183 has been convincingly associated with smoking in peripheral blood cells. 45 However, in lung adenocarcinoma tissue, CpGs near F2RL3 did not show differential methylation associating with smoking according to a recent comprehensive study. 46 Our finding concerned methylation variability with differential methylation and resulted from both tumor and peripheral lung tissue; these differences are likely to explain the difference in F2RL3 methylation. Overall, a limited number of smoking-associated DNA methylation changes were identified in lung adenocarcinoma tissue, particularly when compared to the highly elevated mutation burden associated with smoking. 46 When we analyzed specific findings related to asbestos or smoking collectively, 96% of the elements were interestingly unique to one or other of the exposures. In agreement with the literature, we found that the majority of smoking-associated DMRs and DVMCs and all DMPs were hypomethylated. 47 Importantly, the mean methylation rate appeared to be different in smoking-related CpGs and asbestos exposure status-related CpGs, indicative of a differential genomic DNA methylation profiles of these two exposures. Furthermore, the molecular functions enriched within DVMCs in lung cancer in relation to asbestos exposure (i.e., RNA polymerase II regulatory region DNA binding and calmodulin binding) included sites in genes such as RARB and DAPK that were hypomethylated in lung cancer from the asbestos-exposed cases, whereas previously, hypermethylation in RARB and DAPK has been shown to significantly associate with smoking behavior in lung cancer. 48 Finally, because experiments using sodium bisulfite conversion of DNA cannot distinguish 5-mC from its oxidized form, part of the methylation patterns in our study may involve 5-hydroxymethylcytosine that has recently been implicated particularly at CGI shores. 49 In summary, our genome-wide DNA methylation study, carried out using paired normal and cancerous lung tissues, propose differential DNA methylation profiles in lung cancer cases with well-documented data on exposure to asbestos. Our data suggest an association between asbestos exposure status in lung cancer and aberrant methylation in distinct statistically significant DMRs and DVMCs. Furthermore, we discovered and replicated in a second independent case series, aberrant methylation novel in gene sites in lung cancer, including BEND4, ZSCAN31 and NPTN. The functional effects of small changes in methylation, such as discussed earlier 50 and observed in our study, need clarification in future studies with larger sample sizes in particular targeting smokers with occupational exposure to asbestos. Furthermore, gene expression studies will be necessary to highlight molecular pathways implicated here for asbestos-related lung cancer.
